Search Bar & Filters
Found 35 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating a fully digital, facially guided approach to full-mouth rehabilitation for adults with bite difficulties, smile dissatisfaction, and missing mandibular molars. This study focuses on patients with malocclusion and partial or complete tooth loss who need esthetic and functional dental restoration. The goal is to assess how integrated digital planning combining intraoral, facial, and CBCT scans can improve the precision and outcomes of dental rehabilitation. The treatment uses advanced digital planning to create a 3D virtual patient model that guides esthetic design, occlusion, and implant placement. Participants receive conservative anterior rehabilitation with lithium disilicate veneers, zirconia crowns, guided implant placement for missing molars, and temporary anchorage device-assisted intrusion of extruded molars. This fully digital workflow aims for precise restoration positioning, functional occlusion, and esthetic results. During the study, participants will undergo scans, treatments, and follow-up visits as part of the digital workflow. Researchers will measure implant stability 12 months after treatment to evaluate the success of the rehabilitation. Participants are expected to comply with treatment and follow-up protocols, and will be monitored for functional and esthetic outcomes using integrated digital data throughout the study period.
Actively Recruiting
This research evaluates and compares two non-calibrated splinting systems, IoConnect and Scan Pro, for complete-arch implant digital scans in patients who have no natural teeth and four well-integrated implants connected to multiunit abutments. The study aims to determine the accuracy of implant scans by measuring differences between digital scans and a verified conventional implant impression used as a reference. It also assesses the chairside time required for each scanning procedure to see if there are differences between the two systems. Participants will undergo both digital scanning protocols in a randomized order to avoid bias. The Scan Pro system uses adjustable arms to optically splint implant scan bodies connected to multiunit abutments, while the IoConnect system first captures soft-tissue anatomy and then attaches horizontal scan bodies before merging datasets with dedicated software. A verified conventional splinted implant impression will be obtained beforehand to create a reference digital model for comparison. During the study, the digital scans will be analyzed for linear and angular discrepancies compared to the reference model. Chairside time for each scanning procedure will be recorded. Participants will complete both scanning protocols, and the data will be statistically evaluated to compare accuracy and time. The total participation includes undergoing both scans and associated assessments, with immediate evaluation after each scanning protocol.
Actively Recruiting
Healthy Volunteer
Researchers are evaluating the accuracy of immediate implant placement in patients needing extraction of a lower jaw first or second molar or retained root, followed by implant placement. This study compares three surgical methods freehand surgery, conventional tooth-supported static computer-guided surgery, and a tooth- and socket-supported static surgical guide. The goal is to determine if the type of surgical guide affects the precision of implant positioning in three dimensions. Participants will undergo thorough preoperative digital planning using cone-beam computed tomography and intraoral scanning. They will be randomly assigned to one of three groups freehand implant placement without a guide, implant placement using a conventional tooth-supported static surgical guide, or implant placement using a tooth- and socket-supported static surgical guide that stabilizes on both teeth and the extraction socket. All surgeries are performed by the same experienced clinician with local anesthesia, following standardized protocols to preserve socket anatomy and avoid flap elevation. During the study, participants will receive immediate implant placement according to their assigned surgical approach. After surgery, three-dimensional imaging will compare the planned implant position with the actual implant location, measuring deviations at the implant platform, apex, angle, and depth. The study tracks implant stability and insertion torque at placement. Participants must maintain follow-up visits as scheduled, and the study will run until implant accuracy is assessed immediately after placement.
Actively Recruiting
Researchers are evaluating the clinical performance of maxillary All-on-X full-arch implant-supported rehabilitation using a fully digital stackable guided surgery and immediate loading protocol. This retrospective study focuses on patients with terminal maxillary dentition treated with this approach, aiming to assess implant survival and peri-implant outcomes over a two-year follow-up. The study also investigates how surgical and prosthetic factors, including basal seating guide design, influence these results. Patients received a maxillary All-on-6 implant-supported complete fixed dental prosthesis planned through three-dimensional imaging and dedicated software. Stackable surgical guides were used to enable guided bone reduction when needed, followed by fully guided implant placement under local anesthesia. Implants with sufficient primary stability were immediately loaded with a screw-retained provisional fixed prosthesis on multi-unit abutments. The treatment followed a standardized surgical protocol with occlusal contacts minimized during healing. Participants are followed for at least two years with scheduled clinical and radiographic assessments at prosthesis delivery, one year, and two years. Outcome measures include implant survival at six months post-placement, peri-implant clinical parameters such as plaque index, bleeding on probing, probing depth, and marginal bone level changes assessed by standardized radiographs. The study collects complete clinical and radiographic records to evaluate success according to established criteria.
Actively Recruiting
This research aims to compare two types of ureteral access sheaths used during flexible ureteroscopy to treat kidney stones, known as nephrolithiasis. The study focuses on a novel bendable suction ureteral access sheath with a flexible tip that can reach the renal calyces, compared to a conventional ureteral access sheath. The goal is to evaluate their effectiveness and safety in removing stones, especially for patients with stones smaller than 20 mm, where flexible ureteroscopy is considered a first-line surgical option. Participants will be randomly assigned to one of two groups one group will receive flexible ureteroscopy using the bendable suction ureteral access sheath, while the other group will receive the same procedure with the conventional ureteral access sheath. Both groups undergo minimally invasive surgery with flexible ureteroscopes, and the new device aims to improve surgical vision, reduce pressure inside the kidney, and lower infection risks during treatment. During the study, participants will be monitored for stone-free status immediately after surgery and again at three months postoperatively. Researchers will also track hospital stay duration, need for additional interventions, complications, and costs over three months. The total participation period includes surgery and follow-up assessments up to three months to measure the outcomes and safety of the two devices in treating renal stones.
Actively Recruiting
Researchers are evaluating the effectiveness of cervical erector spinae plane block ESPB in managing pain after surgery for proximal humerus fractures in adults aged 18 to 70 years. This study focuses on patients undergoing general anesthesia for surgical repair of these fractures, which are common in the elderly and especially in women. Postoperative pain is a major concern as it affects recovery, rehabilitation, and long-term function. Participants are randomly assigned to one of two groups one group receives the cervical ESPB after general anesthesia is induced, while the other group receives only general anesthesia without the block. The ESPB is a newer regional anesthesia technique that provides sensory block across multiple spinal levels, potentially reducing pain without affecting motor function. During the study, participants will be monitored for pain levels 24 hours after surgery, as well as other factors like opioid consumption, timing of rescue analgesia, diaphragmatic movement, blood pressure, heart rate, and any complications within 24 hours. The study uses a double-blind design to ensure unbiased results. The total duration includes the surgery and postoperative monitoring up to 24 hours.
Actively Recruiting
Researchers are studying the cardioprotective effects of early administration of dapagliflozin DAPA, a sodium-glucose cotransporter-2 inhibitor, in patients who experience acute myocardial infarction AMI. The study focuses on whether giving DAPA during ischemia and before primary percutaneous coronary intervention pPCI can reduce infarct size, myocardial damage from reperfusion injury, and protect against heart failure HF and acute kidney injury AKI. This area lacks sufficient data, especially regarding the protective effects of DAPA when started early in AMI patients. Participants are randomly assigned to receive either dapagliflozin 10 mg once daily or a matching placebo for three months, starting as early as possible before pPCI. The study compares these two groups to evaluate the effects of the drug on heart and kidney function. The treatment period lasts three months, during which participants continue the assigned medication daily. Throughout the study, participants undergo follow-up assessments to measure infarct size and cardiac biomarkers, including NT-proBNP levels and estimated glomerular filtration rate eGFR, at three months. These measurements help assess heart damage, heart failure risk, and kidney function. The study monitors participants regularly during the treatment period to evaluate the drugs impact and safety over the three months of therapy.
Actively Recruiting
Researchers are evaluating the clinical performance of implant-supported restorations made from 3D-printed permanent resin CROWNTEC compared with conventionally milled monolithic zirconia. The study focuses on single crowns and short-span fixed partial dentures in the front lower jaw, where function and appearance are important. This randomized controlled clinical trial aims to provide evidence on whether 3D-printed resin materials are a viable alternative to zirconia in implant prosthodontics. Participants are randomly assigned to two groups one receiving restorations made with 3D-printed resin using a fully digital workflow including intraoral scanning, CAD design, 3D printing, post-processing, finishing, and polishing the other group receives zirconia restorations made by CAD-CAM milling followed by sintering, finishing, and polishing. Both types of restorations are delivered as screw-retained or cement-retained prostheses. The study includes follow-up visits at baseline, 3, 6, and 12 months, with extended follow-up planned up to 24 months. During the study, participants will have assessments of restoration survival, technical complications like fracture or screw loosening, biological parameters including plaque index and probing depth, and radiographic evaluations of bone level changes. Patient satisfaction with esthetics, comfort, and chewing function is measured using questionnaires. The main outcome is the survival rate of restorations after 12 months. The study period extends up to two years, with ongoing monitoring to understand the performance and limitations of both materials.
Actively Recruiting
Researchers are comparing two prostate biopsy techniques to detect prostate cancer cognitive-targeted biopsy CTB and magnetic resonance imaging-ultrasound fusion-targeted biopsy FTB. The study focuses on biopsy-nafve men suspected of having prostate cancer based on abnormal digital rectal exams and specific prostate-specific antigen PSA levels. It aims to evaluate how accurately each method detects cancer, the pathological results from each biopsy, and how the surgeons performance may affect the procedure. Participants will have a multiparametric MRI of the prostate, and only those with specific suspicious lesions PI-RADS 4 or 5 will join the trial. Each participant undergoes both biopsy methods during the same session under local or regional anesthesia, using a BK3000 ultrasound system. Two surgeons will perform the procedures, and participants are randomly assigned to one of them. This design allows a direct comparison of the two biopsy techniques within the same patient. Throughout the study, researchers will monitor various factors including cancer detection rates based on tissue analysis, clinically significant cancer rates, biopsy procedure time, lesion size on MRI, and procedural details by surgeon. These outcomes will be assessed during the biopsy session. The study is conducted at Menoufia University, with results to be reported after study completion. Participation involves a single biopsy session with detailed imaging and biopsy procedures under professional care.
Actively Recruiting
Researchers are evaluating the safety and effectiveness of different triple therapy treatments to eradicate Helicobacter pylori infection, a bacterium that colonizes the stomach and can lead to serious gastrointestinal diseases including chronic gastritis, peptic ulcers, and gastric cancer. This phase 3 randomized controlled study compares proton pump inhibitor PPI based therapy and vonoprazan-based therapy, both with or without zinc supplementation, to determine their impact on H. pylori eradication and related biological markers. The study involves four treatment groups of 22 patients each. One group receives PPI-based triple therapy with omeprazole or pantoprazole, amoxicillin, and clarithromycin twice daily for 14 days, with another group receiving the same therapy plus zinc sulfate. The other two groups receive vonoprazan-based triple therapy with amoxicillin and clarithromycin, with one group also receiving zinc sulfate. Zinc is being studied for its potential to inhibit H. pylori growth and enhance treatment efficacy. Successful eradication will be confirmed at least 4 weeks after treatment. Participants will be monitored over 8 weeks, with assessments including stool antigen tests to confirm H. pylori eradication and blood tests measuring serum interleukin-6 and pepsinogen levels to evaluate inflammation and gastric health. The Gastrointestinal Symptom Rating Scale is also used to track symptom changes. The study will assess differences in eradication rates and changes in biomarkers and symptoms, providing important data on the comparative effectiveness of therapies with and without zinc supplementation.
1-10 of 35
1